These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 17050805

  • 1. Reversion of structure-activity relationships of antitumor platinum complexes by acetoxime but not hydroxylamine ligands.
    Zorbas-Seifried S, Jakupec MA, Kukushkin NV, Groessl M, Hartinger CG, Semenova O, Zorbas H, Kukushkin VY, Keppler BK.
    Mol Pharmacol; 2007 Jan; 71(1):357-65. PubMed ID: 17050805
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Activation of the trans geometry in platinum antitumor complexes: a survey of the cytotoxicity of trans complexes containing planar ligands in murine L1210 and human tumor panels and studies on their mechanism of action.
    Farrell N, Kelland LR, Roberts JD, Van Beusichem M.
    Cancer Res; 1992 Sep 15; 52(18):5065-72. PubMed ID: 1516063
    [Abstract] [Full Text] [Related]

  • 6. Solution behaviour and biomolecular interactions of two cytotoxic trans-platinum(II) complexes bearing aliphatic amine ligands.
    Cubo L, Casini A, Gabbiani C, Mastrobuoni G, Messori L, Jiménez-Barbero J, Navarro-Ranninger C, Quiroga AG.
    Chemistry; 2009 Sep 14; 15(36):9139-46. PubMed ID: 19655350
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin.
    Komeda S, Kalayda GV, Lutz M, Spek AL, Yamanaka Y, Sato T, Chikuma M, Reedijk J.
    J Med Chem; 2003 Mar 27; 46(7):1210-9. PubMed ID: 12646031
    [Abstract] [Full Text] [Related]

  • 10. Novel trans platinum complexes: comparative in vitro and in vivo activity against platinum-sensitive and resistant murine tumours.
    Goddard PM, Orr RM, Valenti MR, Barnard CF, Murrer BA, Kelland LR, Harrap KR.
    Anticancer Res; 1996 Mar 27; 16(1):33-8. PubMed ID: 8615631
    [Abstract] [Full Text] [Related]

  • 11. cis-[PtCl2(4,7-H-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine)2]: a sterically restrictive new cisplatin analogue. Reaction kinetics with model nucleobases, DNA interaction studies, antitumor activity, and structure-activity relationships.
    Navarro JA, Salas JM, Romero MA, Vilaplana R, Gonzalez-Vílchez F, Faure R.
    J Med Chem; 1998 Jan 29; 41(3):332-8. PubMed ID: 9464364
    [Abstract] [Full Text] [Related]

  • 12. Chemical, biochemical and pharmacological activity of the novel sterically hindered platinum co-ordination complex, cis-[amminedichloro(2-methylpyridine)] platinum(II) (AMD473).
    Holford J, Raynaud F, Murrer BA, Grimaldi K, Hartley JA, Abrams M, Kelland LR.
    Anticancer Drug Des; 1998 Jan 29; 13(1):1-18. PubMed ID: 9474239
    [Abstract] [Full Text] [Related]

  • 13. Novel trans-dichloridoplatinum(II) complexes with 3- and 4-acetylpyridine: Synthesis, characterization, DFT calculations and cytotoxicity.
    Rakić GM, Grgurić-Sipka S, Kaluderović GN, Gómez-Ruiz S, Bjelogrlić SK, Radulović SS, Tesić ZLj.
    Eur J Med Chem; 2009 May 29; 44(5):1921-5. PubMed ID: 19070943
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity.
    Brabec V, Nováková O.
    Drug Resist Updat; 2006 Jun 29; 9(3):111-22. PubMed ID: 16790363
    [Abstract] [Full Text] [Related]

  • 20. Cisplatinum and transplatinum complexes with benzyliminoether ligands; synthesis, characterization, structure-activity relationships, and in vitro and in vivo antitumor efficacy.
    Sbovata SM, Bettio F, Mozzon M, Bertani R, Venzo A, Benetollo F, Michelin RA, Gandin V, Marzano C.
    J Med Chem; 2007 Sep 20; 50(19):4775-84. PubMed ID: 17713897
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.